Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion

The aim of this study was to evaluate the efficacy of a treat-and-extend (T&E) regimen of ranibizumab as the first-choice treatment in macular oedema (MO) secondary to branch retinal vein occlusion (BRVO). We conducted a retrospective study of 20 patients who developed MO due to BRVO treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Fernández, Carmen Antía, Campo-Gesto, Ana, López-López, Aida, Gayoso-Rey, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778817/
https://www.ncbi.nlm.nih.gov/pubmed/35056116
http://dx.doi.org/10.3390/ph15010059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778817/
https://www.ncbi.nlm.nih.gov/pubmed/35056116
http://dx.doi.org/10.3390/ph15010059

Ejemplares similares